Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 60501-60550 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT03874052
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Recruiting
51 participants
Started: Aug 16, 2019 · Completed: Dec 31, 2027
5 conditions4 sponsors3 locations
NCT04057716
Project REST: Regulation of Eating and Sleep Topography
NARecruiting
120 participants
Started: Aug 15, 2019 · Completed: May 29, 2026
4 conditions2 sponsors2 locations
NCT04104412
The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain
PHASE1Recruiting
242 participants
Started: Aug 15, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT04026230
Impact of Atorvastatin on Prostate Cancer Progression During ADT
PHASE3Recruiting
400 participants
Started: Aug 15, 2019 · Completed: Dec 31, 2025
2 conditions12 sponsors10 locations
NCT04083755
Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)
PHASE4Recruiting
240 participants
Started: Aug 15, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors5 locations
NCT04034732
MBRP on Reducing Craving and Addictive Behaviour in Adults
NARecruiting
80 participants
Started: Aug 15, 2019 · Completed: Aug 31, 2024
2 conditions1 sponsor9 locations
NCT04991389
Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics
PHASE4Recruiting
120 participants
Started: Aug 15, 2019 · Completed: Aug 15, 2027
1 condition2 sponsors1 location
NCT04119050
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
PHASE2/PHASE3Recruiting
111 participants
Started: Aug 15, 2019 · Completed: Apr 10, 2028
1 condition1 sponsor171 locations
NCT04033679
The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia
NARecruiting
106 participants
Started: Aug 15, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT03911297
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
N/ARecruiting
1,000 participants
Started: Aug 14, 2019 · Completed: Dec 1, 2027
1 condition10 sponsors1 location
NCT03340129
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
PHASE2Recruiting
218 participants
Started: Aug 14, 2019 · Completed: Aug 31, 2029
1 condition2 sponsors10 locations
NCT05120518
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
N/ARecruiting
150 participants
Started: Aug 14, 2019 · Completed: Aug 14, 2029
1 condition1 sponsor1 location
NCT04046562
Pain and Weight Treatment: Development and Trial of PAW
NARecruiting
50 participants
Started: Aug 14, 2019 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT03513770
Autonomic Control of the Circulation and VDR
EARLY_PHASE1Recruiting
18 participants
Started: Aug 14, 2019 · Completed: May 30, 2026
2 conditions1 sponsor1 location
NCT06108908
Influence of Inhaler Compliance on the Treatment of Asthma Patients
N/ARecruiting
150 participants
Started: Aug 14, 2019 · Completed: Aug 31, 2024
2 conditions2 sponsors1 location
NCT03841058
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
PHASE2Recruiting
96 participants
Started: Aug 14, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT03321370
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
N/ARecruiting
10 participants
Started: Aug 14, 2019 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT04077723
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
PHASE1/PHASE2Recruiting
498 participants
Started: Aug 13, 2019 · Completed: Mar 31, 2027
1 condition1 sponsor39 locations
NCT03713125
Executive Function in Early Childhood
NARecruiting
260 participants
Started: Aug 13, 2019 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06330987
Fetal Autonomic Nervous sysTem Evaluation
N/ARecruiting
186 participants
Started: Aug 13, 2019 · Completed: Dec 28, 2025
8 conditions2 sponsors1 location
NCT03870854
Paced Electrogram Feature Analysis (PEFA) for Ablation Targeting in Ischaemic Ventricular Tachycardia
NARecruiting
40 participants
Started: Aug 13, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor3 locations
NCT03900221
French Registry for Monitoring Pregnancies for Multiple Sclerosis
N/ARecruiting
1,500 participants
Started: Aug 12, 2019 · Completed: Aug 12, 2036
4 conditions1 sponsor46 locations
NCT03929549
Preliminary Evaluation of a RCMP to Predict Failure of Maxillomandibular Advancement Surgery for OSA
NARecruiting
20 participants
Started: Aug 12, 2019 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT04064060
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
PHASE3Recruiting
665 participants
Started: Aug 12, 2019 · Completed: May 12, 2028
3 conditions1 sponsor143 locations
NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
PHASE1/PHASE2Recruiting
345 participants
Started: Aug 12, 2019 · Completed: Nov 15, 2027
2 conditions1 sponsor17 locations
NCT05025150
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
N/ARecruiting
1,020 participants
Started: Aug 11, 2019 · Completed: Dec 8, 2025
2 conditions1 sponsor1 location
NCT04068597
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
PHASE1/PHASE2Recruiting
250 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2027
6 conditions1 sponsor23 locations
NCT03980717
Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH
NARecruiting
80 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT04117230
CARDSUP - SWISS Circulatory Support Registry
N/ARecruiting
1,500 participants
Started: Aug 9, 2019 · Completed: Aug 31, 2034
1 condition1 sponsor5 locations
NCT03899155
Pan Tumor Rollover Study
PHASE2Recruiting
1,500 participants
Started: Aug 9, 2019 · Completed: Aug 25, 2029
1 condition5 sponsors396 locations
NCT03890861
"Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"
NARecruiting
125 participants
Started: Aug 9, 2019 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT04053439
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications
N/ARecruiting
188 participants
Started: Aug 8, 2019 · Completed: Sep 30, 2026
2 conditions3 sponsors1 location
NCT04130659
Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone
NARecruiting
110 participants
Started: Aug 8, 2019 · Completed: Jan 31, 2025
1 condition2 sponsors5 locations
NCT03987958
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
N/ARecruiting
100 participants
Started: Aug 8, 2019 · Completed: Jul 31, 2027
1 condition1 sponsor12 locations
NCT04340505
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
N/ARecruiting
30 participants
Started: Aug 8, 2019 · Completed: Mar 1, 2026
1 condition1 sponsor1 location
NCT03878459
Dapagliflozin Plus Pioglitazone in T1DM
PHASE4Recruiting
120 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT05206643
Shanghai Pudong Cohort
N/ARecruiting
80,000 participants
Started: Aug 7, 2019 · Completed: Dec 31, 2025
1 condition5 sponsors1 location
NCT07185672
PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)
PHASE3Recruiting
162 participants
Started: Aug 7, 2019 · Completed: Aug 7, 2027
3 conditions1 sponsor2 locations
NCT04517513
Shanghai Community Cohort Establishment and Follow-up
N/ARecruiting
80,000 participants
Started: Aug 7, 2019 · Completed: Dec 31, 2025
1 condition5 sponsors1 location
NCT00843375
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
N/ARecruiting
1,200 participants
Started: Aug 7, 2019 · Completed: Mar 31, 2028
1 condition7 sponsors13 locations
NCT04027777
Aktiia OPBM Single-center Prospective Observational Study Against Double Auscultation
NARecruiting
185 participants
Started: Aug 6, 2019 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT03880240
Gamma Induction for Alzheimer's Disease
PHASE1/PHASE2Recruiting
55 participants
Started: Aug 5, 2019 · Completed: Nov 30, 2024
2 conditions4 sponsors1 location
NCT04033614
Fasciotens to Treat an Open Abdomen - a Prospective Cohort Study
NARecruiting
15 participants
Started: Aug 5, 2019 · Completed: Aug 31, 2026
4 conditions2 sponsors1 location
NCT04002947
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
PHASE2Recruiting
132 participants
Started: Aug 5, 2019 · Completed: Mar 31, 2030
4 conditions1 sponsor1 location
NCT03711110
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NARecruiting
514 participants
Started: Aug 2, 2019 · Completed: Nov 30, 2025
4 conditions3 sponsors14 locations
NCT04046237
Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)
NARecruiting
210 participants
Started: Aug 2, 2019 · Completed: Aug 31, 2028
3 conditions2 sponsors1 location
NCT03467360
Phase I Trial of CArbonic Anhydrase Inhibition in Combination with Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma
PHASE1Recruiting
30 participants
Started: Aug 2, 2019 · Completed: Apr 27, 2027
1 condition1 sponsor1 location
NCT04096586
Effects of Watermelon Consumption on Satiety and Digestive Health
NARecruiting
80 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03474029
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
PHASE2/PHASE3Recruiting
3,400 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2029
1 condition1 sponsor16 locations
NCT04038840
Imaging Synapses With [11C] UCB-J in the Human Brain
PHASE1Recruiting
60 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations